Clinical Trial Update: Non-invasive Measures of Effects of Xolair in Asthma [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing non-invasive measures of Xolair effects in asthma has been terminated. Sponsor: University of California, Los Angeles (UCLA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Xolair (omalizumab)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Asthma | Phase 4 | Status: TERMINATED